{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-24-000101","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.295096+00:00","generated_at":"2026-05-31T20:09:04.437159+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elevance Health Q2 diluted EPS $9.85 (+26% YoY); revenue $43.2B, down $0.2B","bullets":["Adjusted diluted EPS $10.12 (+12% YoY); GAAP EPS at least $34.05 for FY2024, adjusted at least $37.20.","Health Benefits revenue $37.2B (-2%); Carelon revenue $13.3B (+10%) on risk-based service growth.","Medical membership 45.8M, down 5% YoY due to Medicaid redeterminations; partly offset by ACA growth.","Benefit expense ratio improved 10 bps to 86.3%; operating expense ratio increased to 11.7%.","Q3 dividend $1.63/share declared, payable Sept 25, 2024; $3.2B share repurchase authorization remaining."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-24-000101","json":"https://secwatch.observer/filing/0001156039-24-000101.json","markdown":"https://secwatch.observer/filing/0001156039-24-000101.md","text":"https://secwatch.observer/filing/0001156039-24-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000101/0001156039-24-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000101/elv-20240717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:09:04.437159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}